Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension

Clinical Chemistry

Volumn 52, Issue 3, 2006, Pages 352-360

  Sanada, Hironobu ^a   Yatabe, Junichi ^a   Midorikawa, Sanae ^a   Hashimoto, Shigeatsu ^a   Watanabe, Tsuyoshi ^a   Moore, Jason H ^b   Ritchie, Marylyn D ^b   Williams, Scott M ^b   Pezzullo, John C ^c   Sasaki, Midori ^d   Eisner, Gilbert M ^c   Jose, Pedro A ^c   Felder, Robin A ^d,e  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCARPAMINE; DOPAMINE 1 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 4; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GENETIC VARIABILITY; GENOTYPE; GRK4 GENE; HUMAN; HUMAN GENOME; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM EXCRETION; VALIDITY;

ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; COHORT STUDIES; DIET; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; MODELS, GENETIC; NATRIURETIC AGENTS; POLYMORPHISM, GENETIC; PRODRUGS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, DOPAMINE D1; RENIN; SODIUM; SODIUM CHLORIDE, DIETARY;

EID: 33644547657     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.059139     Document Type: Article

References (56)

1. Staff of the Division of Epidemiology and Clinical Applications. Long-term plan for research and translation in hypertension for enhancing public health. Summary Report. Bethesda, MD: Division of Heart and Vascular Disease, National Center on Sleep Disorders Research, and Office of Prevention, Education, and Control, NHLBI, 2004:1-57.
2. Kawasaki T, Delea CS, Bartter FC, Smith H. The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med 1978;64:193-8.
3. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001;37:429-32.
4. Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E. Association between salt sensitivity and target organ damage in essential hypertension. Am J Hypertens 2000;13:864-72.
5. de Wardener HE, MacGregor GA. Harmful effects of dietary salt in addition to hypertension. J Hum Hypertens 2002;16:213-23.
6. Hu G, Qiao Q, Tuomilehto J. Nonhypertensive cardiac effects of a high salt diet. Curr Hypertens Rpt 2002;4:13-7.
7. He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999;282:2027-34.
8. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848-51.
9. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997;350:1734-7.
10. Krousel-Wood MA, Muntner P, He J, Whelton PK. Primary prevention of essential hypertension. Med Clin North Am 2004;88:223-38.
11. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8:II-127-II-134.
12. de la Sierra A, Lluch MM, Coca A, Aguilera MT, Giner V, Bragulat E, et al. Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients. Clin Sci 1996;91:155-61.
13. Jose PA, Eisner GM, Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 2002;11:87-92.
14. q/11 proteins in spontaneously hypertensive rats. Am J Physiol 1997;272:F339-46.
15. O'Connell DP, Ragsdale NV, Boyd DG, Felder RA, Carey RM. Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997;29:115-22.
16. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A 2002;99:3872-7.
17. Premont RT, Macrae AD, Stoffel RH, Chung N, Pitcher JA, Ambrose C, et al. Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants. J Biol Chem 1996;271:6403-10.
18. B receptor by GRK4. EMBO J 2003;22:3816-24.
19. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA. Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004;19:233-46.
20. Sanada H, Yatabe J, Yoneda M, Hashimoto S, Midorikawa S, Watanabe T, et al. In vivo targeting of the renal G protein-coupled receptor kinase type 4 (GRKγ) with antisense oligonucleotides induces natriuresis in spontaneously hypertensive rats. Circulation 2002;106(Suppl):II234.
21. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, et al. Genotyping essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem 2002;48:2131-40.
22. Williams SM, Addy JA, Phillips JA III, Dai M, Kpodonu J, Afful J, et al. Combinations of variations in multiple genes are associated with hypertension. Hypertension 2000;36:2-6.
23. Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension 2000;36:183-6.
24. Sugimoto K, Hozawa A, Katsuya T, Matsubara M, Ohkubo T, Tsuji I, et al. α-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J Hypertens 2002;20:1779-84.
25. Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, et al. Low-renin hypertension, altered sodium homeostasis, and an α-adducin polymorphism. Hypertension 2002;39:191-6.
26. Barlassina C, Schork NJ, Manunta P, Citterio L, Sciarrone M, Lanella G, et al. Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000;57:1083-90.
27. Siffert W. G-Protein β3 subunit 825T allele and hypertension. Curr Hypertens Rep 2003;5:47-53.
28. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, et al. Recombinant CYP11β genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab 1998;83:3996-4001.
29. Tiet L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
30. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994;93:1285-7.
31. Baudin B. Angiotensin II receptor polymorphisms in hypertension. Pharmacogenomic considerations. Pharmacogenomics 2002;3:65-73.
32. Poch E, Gonzalez D, Giner V, Bragulat E, Coca A, de la Sierra A. Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension 2001;38:1204-9.
33. Srikumar N, Brown NJ, Hopkins PN, Jeunemaitre X, Hunt SC, Vaughan DE, et al. PAI-1 in human hypertension: relation to hypertensive groups. Am J Hypertens 2002;15:683-90.
34. Sanada H, Asico LD, Shigetomi S, Tanaka K, Niimura S, Watanabe H, et al. The effect of docarpamine, a dopamine pro-drug, on blood pressure and catecholamine levels in spontaneously hypertensive rats. Clin Exp Hypertens 2000;22:419-29.
35. Pharoah PD, Dunning AM, Ponder BA, Easton DF. Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 2004;4:850-60.
36. de la Sierra A, Giner V, Bragulat E, Coca A. LacK of correlation between two methods for the assessment of salt sensitivity in essential hypertension. J Hum Hypertens 2002;16:255-60.
37. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension 1991;17(1 Suppl):161-8.
38. Wirta MR, Hiltunen TP, Lehtimaki T. Rapid detection of angiotensinogen M/T235 polymorphism by fluorescence probe melting curves. Clin Chem 2000;46:880-1.
39. Liu Y, Qin W, Hou S, Shan G, Zhuo M, Chen Y, et al. A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertens Res Clin Exp 2001;24:159-63.
40. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995;332:706-11.
41. Raymond ML, Rousset F. An exact test for population differentiation. Evolution 1995;49:1280-3.
42. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 2001;69:138-47.
43. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003;19:376-82.
44. Miyajima E, Yamada Y. Reduced sympathetic inhibition in salt-sensitive Japanese young adults. Am J Hypertens 1999;12:1195-200.
45. Dichtchekenian V, Sequeira DM, Andriollo A, Marcondes M, Heimann JC. Salt sensitivity in human essential hypertension: effect of renin-angiotensin and sympathetic nervous system blockade. Clin Exp Hypertens 1989;A11(Suppl 1):379-87.
46. Piccirillo G, Bucca C, Durante M, Santagada E, Munizzi MR, Cacciafesta M, et al. Heart rate and blood pressure variabilities in salt-sensitive hypertension. Hypertension 1996;28:944-52.
47. Hurwitz S, Fisher ND, Ferri C, Hopkins PN, Williams GH, Hollenberg NK. Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens 2003;21:951-9.
48. Fisher ND, Hurwitz S, Jeunemaitre X, Hopkins PN, Hollenberg NK, Williams GH. Familial aggregation of low-renin hypertension. Hypertension 2002;39:914-8.
49. Komiya I, Yamada T, Takara M, Asawa T, Shimabukuro M, Mishimori T, et al. Lys(173)Arg and -344T/C variants of CYP11β2 in Japanese patients with low-renin hypertension. Hypertension 2000;35:699-703.
50. Moore JH, Williams SM. New strategies for identifying gene-gene interactions in hypertension. Ann Med 2002;34:88-95.
51. Williams SM, Ritchie MD, Phillips JA III, Dawson E, Prince M, Dzhura E, et al. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered 2004;57:28-38.
52. Lohmueller KE, Wong LJ, Mauney MM, Jiang L, Felder RA, Jose PA, et al. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet;in press.
53. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 2004;22:931-6.
54. Wang Z, Asico LD, Felder RA, Robillard JE, Jose PA. Human GRK4A486V polymorphism causes salt sensitive hypertension in transgenic mice [Abstract]. Am Soc Nephrol 2003;14:362A.
55. Wang Z, Asico LD, Felder RA, Robillard JE, Jose PA. Human GRK4γ A142V variant produces hypertension in transgenic mice [Abstract]. FASEB J 2004;18:A353.
56. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991;18:67-71.